Medora Pharmaceutical Private Limited

Medora Pharmaceutical Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U51397DL2013PTC249013 Incorporated 04 March 2013 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma
Data last updated
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2024
Balance sheet date
Last AGM
23 Sep 2024
Annual general meeting
Company status
Active
MCA master data

About Medora Pharmaceutical Private Limited

Data last updated:

Medora Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 March 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2013PTC249013. Its GSTIN is 06AAICM5378A1ZJ (Haryana).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rakesh Kumar and Rameshsingh Harisingh Thakur.

Its last annual general meeting (AGM) was held on 23 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 47 – A Vishwakarma Park Laxmi Nagar, Delhi, India – 110092.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51397DL2013PTC249013
Registration Number 249013
Incorporation Date 04 March 2013
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant

Contact details

Medora Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    47 – A Vishwakarma Park Laxmi Nagar, Delhi, India – 110092
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Medora Pharmaceutical Private Limited, buy the company report.

Comprehensive company report
Medora Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Medora Pharmaceutical Private Limited

FY 2024 filings available

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medora Pharmaceutical Private Limited, buy the company report.

Board of directors of Medora Pharmaceutical Private Limited

Medora Pharmaceutical has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rakesh KumarAdditional Director24 Dec 20241 Years 10 MonthsCurrent
Rameshsingh Harisingh ThakurAdditional Director24 Dec 20241 Years 10 MonthsCurrent
Anil Tribhuvan VishwakarmaAdditional Director24 Dec 20241 Years 10 MonthsCurrent

Auditor

Medora Pharmaceutical Private Limited is audited by PINKI & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
PINKI & ASSOCIATESFY 2023022783N

Shareholding

The shareholding of Medora Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Medora Pharmaceutical Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medora Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Medora Pharmaceutical has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAICM5378A1ZJHaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of Medora Pharmaceutical Private Limited, buy the company report.

Recent activity

Medora Pharmaceutical Private Limited has 10 board changes on record since 2013: 3 appointments and 7 cessations. The latest: Anil Tribhuvan Vishwakarma was appointed as Additional Director on 24 Dec 2024.

Appointed
Anil Tribhuvan Vishwakarma was appointed as Additional Director.
Appointed
Rakesh Kumar was appointed as Additional Director.
Appointed
Rameshsingh Harisingh Thakur was appointed as Additional Director.
AGM
Medora Pharmaceutical Private Limited last Annual general meeting of members was held on 23 Sep 2024 as per latest MCA records.
Filing
Medora Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Hemant Kumar ceased to be Additional Director.
Ceased
Suresh Gupta ceased to be Director.
Ceased
Rameshsingh Harisingh Thakur ceased to be Additional Director.
Ceased
Geeta Singhal ceased to be Director.
Ceased
Tina Singhal ceased to be Additional Director.
Ceased
Rakesh Dhawan ceased to be Director.
Ceased
Anju Verma ceased to be Director.

1 earlier event is in the company report.

Frequently asked questions

Medora Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 March 2013 (13+ years old) and is registered under CIN U51397DL2013PTC249013.

Medora Pharmaceutical has 3 current directors:

The latest financial statements of Medora Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 23 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Medora Pharmaceutical is 06AAICM5378A1ZJ, registered in Haryana.

The CIN (Corporate Identification Number) of Medora Pharmaceutical is U51397DL2013PTC249013. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medora Pharmaceutical was incorporated on 04 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.

Anil Tribhuvan Vishwakarma was appointed as Additional Director on 24 Dec 2024. Rakesh Kumar was appointed as Additional Director on 24 Dec 2024. Rameshsingh Harisingh Thakur was appointed as Additional Director on 24 Dec 2024. Medora Pharmaceutical has 10 board changes on record in total.

The registered office of Medora Pharmaceutical is at 47 – A Vishwakarma Park Laxmi Nagar, Delhi, India – 110092.

Medora Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Medora Pharmaceutical is compliant as of 09 August 2026. The company is actively filing with the Registrar of Companies.